P Douste‐Blazy

806 citations

27 papers · 625 indexed · h-index 11

Impact in

Endocrinology, Diabetes and Metabolism top 5%
- Diabetes, Cardiovascular Risks, and Lipoproteins
Cancer Research
- Cancer, Lipids, and Metabolism

Papers in

Internal Medicine 2
Toxicology 1

Co-authors: H J Parra A. Bingham Dorothy McMaster Jean‐Pierre Cambou Dominique Arveiler P Schaffer G. Luc Philippe Amouyel
Journals: Metabolism (2 papers)Human Mutation (1 paper)Clinical Cardiology (1 paper)QJM (1 paper)European Heart Journal (1 paper)
Partner nations: France Switzerland Germany

In The Last Decade

P Douste‐Blazy

26 papers receiving 590 citations

Peers

Countries citing papers authored by P Douste‐Blazy

Since Specialization

Citations

This map shows the geographic impact of P Douste‐Blazy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P Douste‐Blazy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P Douste‐Blazy more than expected).

Fields of papers citing papers by P Douste‐Blazy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P Douste‐Blazy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P Douste‐Blazy. The network helps show where P Douste‐Blazy may publish in the future.

Co-authors

The 25 scholars most cited alongside P Douste‐Blazy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with P Douste‐Blazy Line = papers co-authored together P Douste‐Blazy links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Autres pays, autres coeurs? Dietary patterns, risk factors and ischaemic heart disease in Belfast and Toulouse QJM ·A. Evans, J. B. Ruidavets, E. McCrum, Jean‐Pierre Cambou, R McClean, P Douste‐Blazy, Dorothy McMaster, A. Bingham, C. C. Patterson, J L Richard, AA.VV. AA.VV., François Cambien	1995	57
2	Human type II hyperlipoproteinemia enhances platelet-collagen adhesion in flowing nonanticoagulated blood. Arteriosclerosis and Thrombosis A Journal of Vascular Biology ·Y Cadroy, L. Smentek, Armelle Diquélou, Jean Ferrières, P Douste‐Blazy, B Boneu, Kjell S. Sakaríassen	1993	10
3	A multicenter comparison of the effects of simvastatin and fenofibrate therapy in severe primary hypercholesterolemia, with particular emphasis on lipoproteins defined by their apolipoprotein composition Metabolism ·Jean‐Marie Bard, H J Parra, Brian Andersen, Yoga Alvin Adrian, Olivier Ziegler, C. Dachet, Éric Bruckert, P Douste‐Blazy, Pierre Drouin, B Jacotot, J. L. de Gennes, Ulrich Keller, Jean‐Charles Fruchart	1992	67
4	Screening for new mutations in the LDL receptor gene in seven French familial hypercholesterolemia families by the single strand conformation polymorphism method Human Mutation ·Garry Poluan, Bruno Saint-Jore, (unknown), Anas Abbas, Pascale Benlian, J Truffert, B. Dastugue, P Douste‐Blazy, J. L. de Gennes, Claudine Junien, Cathérine Boileau	1992	26
5	Lipoprotein particle analysis comparing simvastatin and fenofibrate Atherosclerosis ·Jean‐Marie Bard, Muneharu Kutsuna, G. Luc, Brian Andersen, Olivier Ziegler, C. Dachet, Éric Bruckert, P Douste‐Blazy, Pierre Drouin, B Jacotot, J. L. de Gennes, Ulrich Keller, J C Fruchart	1991	8
6	Comparison of dietary patterns between population samples in the three French MONICA nutritional surveys. PubMed ·Kaiqi Ma, C. Simón, M C Nuttens, A. Bingham, J. B. Ruidavets, J.-P. Cambou, Dominique Arveiler, Jean Lecerf, J.L. Schlienger, P Douste‐Blazy	1990	21
7	Effect of pravastatin, an HMG CoA reductase inhibitor, and cholestyramine, a bile acid sequestrant, on lipoprotein particles defined by their apolipoprotein composition Metabolism ·Jean‐Marie Bard, H J Parra, P Douste‐Blazy, J.C. Fruchart	1990	46
8	[Evaluation of mortality caused by ischemic heart disease in Haute-Garonne]. PubMed ·J.B. Ruidavets, J.-P. Cambou, M Latofski-Robles, J. L. Richard, P Bernadet, P Douste‐Blazy	1990	2
9	Between-register and within-register variability in event-finding and rates in the MONICA-France Project. PubMed ·J L Richard, Dominique Arveiler, J.-P. Cambou, M C Nuttens, A. Bingham, J.B. Ruidavets, P Schaffer, Jean‐Louis Salomez, P Douste‐Blazy	1990	6
10	[The efficacy and tolerance of simvastatin and fenofibrate in primary hypercholesterolemia]. PubMed ·Elizabeth Lim, P Douste‐Blazy, Pierre Drouin, J. L. de Gennes, C. Dachet, U Keller	1990	5
11	A LDL receptor gene homozygous mutation: PCR amplification, direct genomic sequencing, associated haplotype, rapid screening for frequency. PubMed ·Pascale Benlian, Serge Amselem, Garry Poluan, D. Pastier, G Giraud, J. L. de Gennes, G Turpin, Louis Monnier, D. Rieu, P Douste‐Blazy	1990	2
12	Effect of simvastatin on plasma lipids, apolipoproteins and lipoprotein particles in patients with primary hypercholesterolaemia European Journal of Clinical Pharmacology ·Jean‐Marie Bard, Yoga Alvin Adrian, P Douste‐Blazy, Pierre Drouin, Olivier Ziegler, B Jacotot, C. Dachet, J. L. de Gennes, J.C. Fruchart	1989	16
13	Comparison of cardiovascular risk factor levels in two French populations: Haute‐Garonne (Toulouse) and Bas‐Rhin (Strasbourg) Acta Medica Scandinavica ·P Douste‐Blazy, J.B. Ruidavets, Dominique Arveiler, A. Bingham, Brian Andersen, P Schaffer, Brandon Alton Scott, J. L. Richard	1988	7
14	Effect of fenofibrate on apolipoprotein B containing lipoprotein particles. PubMed ·Pedro Barreira Silva da Rocha, Jean‐Marie Bard, Catherine Fiévet, A. Kandoussi, Mohamed Naceur Slimane, P Douste‐Blazy	1988	1
15	[Cardiovascular risk factors in the population of 2 regions covered by the MONICA-France regions: Strasbourg and Toulouse]. PubMed ·P Douste‐Blazy, Ruidavets Jb, D. A. T. Harpe, A. Bingham, Alexander Dmitrishin, Brian Andersen, P Schaffer, Richard Jl	1988	5
16	[Metabolism of cholesterol: the LDL receptor pathway]. PubMed ·P Douste‐Blazy	1987	2
17	Renal side effect of nifedipine Clinical Cardiology ·Jacques P. Pourrat, P Douste‐Blazy	1984	11
18	Exercise-Induced Platelet Activation in Myocardial Infarction Survivors with Normal Coronary Arteriogram Thrombosis and Haemostasis ·P Douste‐Blazy, Piérre Siè, B Boneu, Jean Marco, N. Eche, P Bernadet	1984	20
19	Abnormal in Vivo Platelet Activation During Exercise in Patients with Effort Kyocardial Infarction and Normal Coronary Arteriogram European Heart Journal ·P Douste‐Blazy, Piérre Siè, B Boneu, Jean Marco, P Bernadet	1983	1
20	Characterization of monoclonal antibodies against human apolipoprotein E. Journal of Clinical Investigation ·R W Milne, P Douste‐Blazy, Yves L. Marcel, L.A. Retegui	1981	76

About P Douste‐Blazy

P Douste‐Blazy is a scholar working on Internal Medicine, Toxicology, Surgery, Endocrinology, Diabetes and Metabolism and General Health Professions, having authored 27 papers that have together received 625 indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (10 papers), Healthcare Systems and Practices (6 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers), Health, Medicine and Society (3 papers), Nutritional Studies and Diet (3 papers), Health Promotion and Cardiovascular Prevention (3 papers), Antiplatelet Therapy and Cardiovascular Diseases (2 papers) and Cancer, Lipids, and Metabolism (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (259 citations), Cancer Research (110 citations), Surgery (302 citations), Cardiology and Cardiovascular Medicine (147 citations) and Biochemistry (29 citations). P Douste‐Blazy has collaborated with scholars based in France, Switzerland and Germany. Frequent co-authors include H J Parra, A. Bingham, Dorothy McMaster, Jean‐Pierre Cambou, Dominique Arveiler, P Schaffer, G. Luc, Philippe Amouyel, A. E. Evans and R W Milne. Their work appears in journals such as Metabolism, Human Mutation, Clinical Cardiology, QJM and European Heart Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact